Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8143216 Modified human growth hormone

Patent 8143216 was granted and assigned to Ambrx on March, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ambrx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81432160

Patent Inventor Names

Anna-Maria A. Hays0

Richard D. DiMarchi0

Thomas O. Daniel0

Troy E. Wilson0

Bee-Cheng Sim0

David C. Litzinger0

Ho Sung Cho0

Date of Patent

March 27, 2012

Patent Application Number

119241010

Date Filed

October 25, 2007

Patent Citations Received

‌

US Patent 11786578 Modified relaxin polypeptides and their uses

Patent Primary Examiner

‌

Daniel C Gamett

Patent abstract

Modified growth hormone polypeptide and uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8143216 Modified human growth hormone

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API